BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26248895)

  • 1. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
    Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
    Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating GNAS mutations in parosteal osteosarcoma.
    Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
    Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
    Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAS Mutations in Fibrous Dysplasia: A Comparative Study of Standard Sequencing and Locked Nucleic Acid PCR Sequencing on Decalcified and Nondecalcified Formalin-fixed Paraffin-embedded Tissues.
    Jour G; Oultache A; Sadowska J; Mitchell T; Healey J; Nafa K; Hameed M
    Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):660-667. PubMed ID: 26574629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions.
    Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Decouvelaere AV; Bouvier C; Larousserie F; Marie B; Delfour C; Aubert S; Rosset P; de Muret A; Pagès JC; de Pinieux G
    Mod Pathol; 2013 Jul; 26(7):911-21. PubMed ID: 23370769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
    Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
    Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
    Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene amplification and tumor grading in parosteal osteosarcoma.
    Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
    J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].
    Li L; Zhang M; Dong RF; Su YB; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):237-242. PubMed ID: 38433050
    [No Abstract]   [Full Text] [Related]  

  • 12. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.
    Shi RR; Li XF; Zhang R; Chen Y; Li TJ
    Mod Pathol; 2013 Aug; 26(8):1023-31. PubMed ID: 23503642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
    He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
    Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations in osteosarcomas of low-grade malignancy.
    Radig K; Schneider-Stock R; Haeckel C; Neumann W; Roessner A
    Hum Pathol; 1998 Nov; 29(11):1310-6. PubMed ID: 9824113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on Carter et al's "activating GNAS mutations in parosteal osteosarcoma".
    Tabareau-Delalande F; Collin C; Larousserie F; Bouvier C; Gomez-Brouchet A; Aubert S; Guinebretière JM; Decouvelaere AV; de Muret A; Pagès JC; de Pinieux G
    Am J Surg Pathol; 2015 Jul; 39(7):1010-3. PubMed ID: 25970689
    [No Abstract]   [Full Text] [Related]  

  • 18. MDM2 and CDK4 expression in periosteal osteosarcoma.
    Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
    Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
    Pollandt K; Engels C; Kaiser E; Werner M; Delling G
    Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
    Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
    Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.